Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia

Neurology

Volumn 50, Issue 6, 1998, Pages 1837-1841

  Watson, C Peter N ^a,b   Babul, Najib ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Department of Scientific Affairs ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYCODONE;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISABILITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION;

EID: 0031780851     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.50.6.1837     Document Type: Article

References (34)

1. Watson CPN. Medical treatment of postherpetic neuralgia. In: Watson CPN, ed. Herpes zoster and postherpetic neuralgia. 1st edition. The Netherlands: Elsevier, 1993:205-219.
2. Watson CPN. Postherpetic neuralgia. Neurol Clin 1989;7:231-248.
3. Watson CPN. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage 1994;9:392-405.
4. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Walsh S. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-673.
5. Max MD, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline but not lorazepam relieves postherpetic neuralgia. Neurology 1988;38:1427-1432.
6. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990;47: 305-312.
7. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in postherpetic neuralgia. Pain 1985;23:387-394.
8. Watson CPN, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992;48:29-36.
9. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256.
10. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic non-malignant pain. J Pain Symptom Manage 1992;7:69-77.
11. Kanner R, Duarte R. Controlled-release morphine (CRM) in the treatment of pain of non-malignant origin. Paper presented at: Annual Meeting of the American Pain Society; November 7-10, 1991; New Orleans, LA.
12. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996; 11:203-217.
13. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171-186.
14. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In: Kitahata LM, Collins D, eds. Narcotic analgesics in anesthesiology. Baltimore: Williams and Wilkins, 1982:199-208.
15. Tennant FS, Robinson D, Sagherian AS, Seecof R. Chronic opioid treatment of intractable non-malignant pain. Pain Management 1988;Jan/Feb:18-26.
16. Tennant FS, Uelmen GF. Narcotic maintenance for chronic pain: medical and legal guidelines. Postgrad Med J 1983;73: 81-94.
17. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984;19:1379-1382.
18. Wan Lu C, Urban B, France RD. Long-term narcotic therapy in chronic pain. Presented at the Canadian Pain Society and American Pain Society Joint Meeting; November 10-13, 1988; Toronto, Canada.
19. Portenoy RK. Opioid therapy. In: Tollison CD, Kriegel ML, eds. Interdisciplinary rehabilitation of low back pain. Baltimore: Williams and Wilkins, 1989:137-157.
20. Knight CL. The use of opioids for chronic pain in non-malignant disease. In: Twycross RG, ed. The Edinburgh symposium on pain control and medical education. Royal Society of Medicine Services International Congress and Symposium Series No. 149. Edinburgh: Royal Society of Medicine, 1989: 201-204.
21. Pappagallo M, Campbell JN. Chronic opioid therapy as alternative treatment for post-herpetic neuralgia. Ann Neurol 1994;35:S54-S56.
22. Urban BJ, France RD, Steinberger EK, Scott DL, Maltbie AA. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 1986;24:191-196.
23. Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z, Darke AC. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995;62:169-178.
24. Moulin DE, Iezzi A, Amireh R, Sharpe WKJ, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143-147.
25. Rowbotham M, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce pain of postherpetic neuralgia. Neurology 1991;41:1024-1028.
26. Dellemijn PLI, Vanneste JAL. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997;349:753-758.
27. McNair DM, Lorr M, Droppleman LF. Profile of mood states. San Diego, CA: Educational and Industrial Testing Service, 1971.
28. Beck AT, Beamesderfer A. Assessment of depression, the depression inventory. Mod Probl Pharmacopsychiatry 1974;7: 151-169.
29. Jacox AK, Carr DB, Payne R, et al. Management of cancer pain. Clinical practice guideline No. 9. Rockville, MD: Agency for Health Care Policy and Research, 1994 (ACPHR publication no. 94-0592).
30. Beaver WT, Wallenstein SL, Rogers A, Houde RW. Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of oral with intramuscular oxycodone and of oral with intramuscular morphine and codeine. Pharmacol Ther 1978;207:101-108.
31. Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 1990; 47:639-646.
32. Kantor TG, Hopper M, Laska E. Adverse effects of commonly ordered oral narcotics. J Clin Pharmacol 1981;21:1-8.
33. Hagen NA, Babul N. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer 1997;79:1428-1437.
34. Kishore-Kumar R, Schafer SC, Lawlor BA, Murphy DL, Max MB. Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain 1989;37:223-227.